MARTORANA, ALESSANDRO
MARTORANA, ALESSANDRO
Dipartimento di Medicina dei sistemi
"Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals"
2014-09-23 Martorana, A; Di Lorenzo, F; Manenti, G; Semprini, R; Koch, G
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus
2015-04-23 Schirinzi, T; Sancesario, G; Ialongo, C; Imbriani, P; Madeo, G; Toniolo, S; Martorana, A; Pisani, A
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation?
2010-06-01 Sancesario, G; Esposito, Z; Nuccetelli, M; Sorge, Rp; Martorana, A; Federici, G; Bernardi, G; Bernardini, S; Sancesario, G
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway
2003-06-15 Pisani, A; Bonsi, P; Centonze, D; Martorana, A; Fusco, F; Sancesario, G; De Persis, C; Bernardi, G; Calabresi, P
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis
2005-10-15 Stefani, A; Bernardini, S; Panella, M; Pierantozzi, M; Nuccetelli, M; Koch, G; Urbani, A; Giordano, A; Martorana, A; Orlacchio, A; Federici, G; Bernardi, G
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis.
2005-01-01 Stefani, A; Bernardini, S; Panella, M; Pierantozzi, M; Nuccetelli, M; Koch, G; Urbani, A; Giordano, A; Martorana, A; Orlacchio, A; Federici, G; Bernardi, G
Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene
2008-01-01 Massa, R; Bruno, C; Martorana, A; De Stefano, N; Van Diggelen, O; Federico, A
Ageing as a Trait de Union between diabetes and dementia for frailty
2013-01-01 Semprini, R; Ragonese, M; Poggi, M; Franze, A; Martorana, A
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients
2011-01-01 Koch, G; Esposito, Z; Codecà, C; Mori, F; Kusayanagi, H; Monteleone, F; Di Lorenzo, F; Bernardi, G; Martorana, A
Alzheimer’s disease and the routine clinical use of CSF biomarkers
2017-01-01 Martorana, A
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?
2013-08-01 Esposito, Z; Belli, L; Toniolo, S; Sancesario, G; Bianconi, C; Martorana, A
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease
2018-02-01 Schirinzi, T; Di Lorenzo, F; Sancesario, G; Di Lazzaro, G; Ponzo, V; Pisani, A; Mercuri, N; Koch, G; Martorana, A
Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease
2011-01-01 Cesareo, M; Greco, P; Martucci, A; Chiarucci, M; Martorana, A; Sorge, R; Sancesario, G; Cerulli, L; Nucci, C
Assessment of serum uric acid as risk factor for tauopathies
2017-06-15 Schirinzi, T; Di Lazzaro, G; Colona, Vl; Imbriani, P; Alwardat, M; Sancesario, Gm; Martorana, A; Pisani, A
Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry
2015-01-01 Cesareo, M; Martucci, A; Ciuffoletti, E; Mancino, R; Cerulli, A; Sorge, Rp; Martorana, A; Sancesario, G; Nucci, C
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity.
2006-01-01 Demarch, Z; Giampa, C; Patassini, S; Martorana, A; Bernardi, G; Fusco, F
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?
2010-08-01 Martorana, A; Esposito, Z; Koch, G
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias
2021-06-01 Bonomi, Cg; De Lucia, V; Mascolo A. P. b, Am; Motta, C; Scaricamazza, E; Sallustio, F; Mercuri, Nb; Koch, G; Martorana, A
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study
2018-01-01 Chiaravalloti, A; Barbagallo, G; Ricci, M; Martorana, A; Ursini, F; Sannino, P; Karalis, G; Schillaci, O
Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients?
2019-06-01 Chiaravalloti, A; Barbagallo, G; Martorana, A; Castellano, Ae; Ursini, F; Schillaci, O
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 23-set-2014 | "Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" | Martorana, A; Di Lorenzo, F; Manenti, G; Semprini, R; Koch, G | Articolo su rivista | |
| 23-apr-2015 | A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus | Schirinzi, T; Sancesario, G; Ialongo, C; Imbriani, P; Madeo, G; Toniolo, S; Martorana, A; Pisani, A | Articolo su rivista | |
| 1-giu-2010 | Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? | Sancesario, G; Esposito, Z; Nuccetelli, M; Sorge, Rp; Martorana, A; Federici, G; Bernardi, G; Bernardini, S; Sancesario, G | Articolo su rivista | |
| 15-giu-2003 | Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway | Pisani, A; Bonsi, P; Centonze, D; Martorana, A; Fusco, F; Sancesario, G; De Persis, C; Bernardi, G; Calabresi, P | Articolo su rivista | |
| 15-ott-2005 | AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis | Stefani, A; Bernardini, S; Panella, M; Pierantozzi, M; Nuccetelli, M; Koch, G; Urbani, A; Giordano, A; Martorana, A; Orlacchio, A; Federici, G; Bernardi, G | Articolo su rivista | |
| 1-gen-2005 | AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. | Stefani, A; Bernardini, S; Panella, M; Pierantozzi, M; Nuccetelli, M; Koch, G; Urbani, A; Giordano, A; Martorana, A; Orlacchio, A; Federici, G; Bernardi, G | Articolo su rivista | |
| 1-gen-2008 | Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene | Massa, R; Bruno, C; Martorana, A; De Stefano, N; Van Diggelen, O; Federico, A | Articolo su rivista | |
| 1-gen-2013 | Ageing as a Trait de Union between diabetes and dementia for frailty | Semprini, R; Ragonese, M; Poggi, M; Franze, A; Martorana, A | Articolo su rivista | |
| 1-gen-2011 | Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients | Koch, G; Esposito, Z; Codecà, C; Mori, F; Kusayanagi, H; Monteleone, F; Di Lorenzo, F; Bernardi, G; Martorana, A | Articolo su rivista | |
| 1-gen-2017 | Alzheimer’s disease and the routine clinical use of CSF biomarkers | Martorana, A | Articolo su rivista | |
| 1-ago-2013 | Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? | Esposito, Z; Belli, L; Toniolo, S; Sancesario, G; Bianconi, C; Martorana, A | Articolo su rivista | |
| 1-feb-2018 | Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease | Schirinzi, T; Di Lorenzo, F; Sancesario, G; Di Lazzaro, G; Ponzo, V; Pisani, A; Mercuri, N; Koch, G; Martorana, A | Articolo su rivista | |
| 1-gen-2011 | Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease | Cesareo, M; Greco, P; Martucci, A; Chiarucci, M; Martorana, A; Sorge, R; Sancesario, G; Cerulli, L; Nucci, C | Intervento a convegno | |
| 15-giu-2017 | Assessment of serum uric acid as risk factor for tauopathies | Schirinzi, T; Di Lazzaro, G; Colona, Vl; Imbriani, P; Alwardat, M; Sancesario, Gm; Martorana, A; Pisani, A | Articolo su rivista | |
| 1-gen-2015 | Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry | Cesareo, M; Martucci, A; Ciuffoletti, E; Mancino, R; Cerulli, A; Sorge, Rp; Martorana, A; Sancesario, G; Nucci, C | Articolo su rivista | |
| 1-gen-2006 | Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. | Demarch, Z; Giampa, C; Patassini, S; Martorana, A; Bernardi, G; Fusco, F | Articolo su rivista | |
| 1-ago-2010 | Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? | Martorana, A; Esposito, Z; Koch, G | Articolo su rivista | |
| 1-giu-2021 | Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias | Bonomi, Cg; De Lucia, V; Mascolo A. P. b, Am; Motta, C; Scaricamazza, E; Sallustio, F; Mercuri, Nb; Koch, G; Martorana, A | Articolo su rivista | |
| 1-gen-2018 | Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study | Chiaravalloti, A; Barbagallo, G; Ricci, M; Martorana, A; Ursini, F; Sannino, P; Karalis, G; Schillaci, O | Articolo su rivista | |
| 1-giu-2019 | Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients? | Chiaravalloti, A; Barbagallo, G; Martorana, A; Castellano, Ae; Ursini, F; Schillaci, O | Articolo su rivista |